ISEMBYLD Trademark

Trademark Overview


On Monday, December 19, 2022, a trademark application was filed for ISEMBYLD with the United States Patent and Trademark Office. The USPTO has given the ISEMBYLD trademark a serial number of 97723538. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Friday, March 8, 2024. This trademark is owned by Scholar Rock, Inc.. The ISEMBYLD trademark is filed in the Pharmaceutical Products category with the following description:

Monoclonal antibodies for medical purposes; pharmaceutical preparations, namely, antibodies for the treatment of spinal muscular atrophy (SMA); therapeutic preparations comprising apitegromab, being a monoclonal antibody for the diagnosis, treatment, and prevention of spinal muscular atrophy (SMA), musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders; therapeutic agents and pharmaceutical preparations for the diagnosis, treatment, and prevention of musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders
isembyld

General Information


Serial Number97723538
Word MarkISEMBYLD
Filing DateMonday, December 19, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateFriday, March 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 31, 2023

Trademark Statements


Goods and ServicesMonoclonal antibodies for medical purposes; pharmaceutical preparations, namely, antibodies for the treatment of spinal muscular atrophy (SMA); therapeutic preparations comprising apitegromab, being a monoclonal antibody for the diagnosis, treatment, and prevention of spinal muscular atrophy (SMA), musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders; therapeutic agents and pharmaceutical preparations for the diagnosis, treatment, and prevention of musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes052, 051, 005, 018, 006, 044, 046
Class Status Code6 - Active
Class Status DateThursday, December 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameScholar Rock, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameScholar Rock, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Saturday, March 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 8, 2024SOU EXTENSION 1 GRANTED
Friday, March 8, 2024SOU EXTENSION 1 FILED
Friday, March 8, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, December 26, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 31, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 31, 2023PUBLISHED FOR OPPOSITION
Wednesday, October 11, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 25, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 25, 2023EXAMINER'S AMENDMENT ENTERED
Monday, September 25, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, September 25, 2023EXAMINERS AMENDMENT E-MAILED
Monday, September 25, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 20, 2023ASSIGNED TO EXAMINER
Thursday, December 22, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 22, 2022NEW APPLICATION ENTERED